Rx PHARMASIST.CA
The Pharmasist newsletter

Stay current in
Canadian pharmacy.

Pharmacy news, practice updates and fresh perspectives—delivered to your inbox.

Keep your practice informed

  • Canadian pharmacy news

    Follow the developments shaping the profession.

  • Prescriber updates

    Stay informed about newly licensed Ontario physicians.

  • What's new on Pharmasist

    Explore new resources, tools and learning opportunities.

Free newsletter

A useful addition to your inbox.

We'll send a confirmation link first. Privacy policy

All news Pharmasist News & insight

GreenShield issues Ontario update on prescription limits, DUR codes, compounds and OHIP+

GreenShield’s November Ontario bulletin covers initial prescription supplies, DUR intervention codes, electronic compound claims, OHIP+ payer order for KARE members and an updated claims manual.

6 min read4 sources
Share LinkedIn X Facebook Email
Illustrative photo accompanying this news article
Illustrative pharmacy mortar and pestle. Tamorlan / Wikimedia Commons, CC BY 3.0. Resized. Image source
In this article & details

Article details

Published
Nov 19, 2026
Reading time
6 min read
Categories
Pharmacy Practice
Jurisdiction
Ontario
Sources cited
4
All news

GreenShield’s November Ontario pharmacy update, distributed on November 19, addresses initial prescription supplies, drug-utilization review messages, electronic compound claims and OHIP+ billing for eligible KARE members. The insurer also announces that its updated Pharmacy Claims Manual is available on providerConnect.

The bulletin combines existing claims reminders with a newly announced simplification for compounded medications. GreenShield reiterates its 30-day initial limit for new low-cost prescriptions and a separate 10-day limit for certain high-cost drugs, explains the intervention codes accompanying DUR responses, and directs pharmacies to bill OHIP+ first for eligible KARE members aged 24 or younger.

For compounds, GreenShield says more claims can now be submitted electronically using an eligible drug identification number, natural product number or GreenShield compound PIN. It says the change is intended to reduce manual submissions and follow-up and make real-time adjudication more consistent.

Initial supplies: 30 days for new low-cost prescriptions, 10 for certain high-cost drugs

GreenShield reiterates an initial maximum of 30 days for new prescriptions for low-cost drugs. It treats a prescription as new when the member has not received the identical drug in the preceding 12 months, regardless of the pharmacy. A dose adjustment or a switch between brands, including generic substitution, does not count as starting a new drug.

Claims exceeding the initial limit return the OF response and may be resubmitted with a reduced days’ supply. The bulletin says a pharmacist may use professional judgment where a shorter initial supply is inappropriate, such as when a patient is already established on treatment before joining GreenShield or was stabilized in hospital. The NH intervention code communicates that decision, and the reason must be documented.

Certain high-cost drugs have a separate initial maximum of 10 days, followed by a maximum 30-day supply once tolerance is established. These are existing policies reiterated in the November communication: both initial-supply programs appear in GreenShield’s September 2024 claims manual.

DUR responses still require the appropriate documented action

The bulletin distinguishes informational drug-utilization review messages from overridable warnings. Informational messages do not require an intervention code. Overridable warnings require the pharmacist’s judgment, an appropriate intervention code and pharmacist identification before payment. GreenShield accepts no more than two intervention codes per transaction.

The ME drug-interaction response is an overridable warning for severity levels 1 and 3, with payment withheld pending an appropriate intervention. The bulletin lists codes for consulting the prescriber and dispensing as written (UA), changing instructions (UC) or dose (UB), accepting the patient’s explanation (UF), consulting another source (UI), or cautioning the patient (UG). Severity level 2 is an informational response with the claim approved; the table also identifies UD for changing the drug after prescriber consultation and UL for a pharmacist’s decision not to dispense.

For a D7 early-refill warning, GreenShield lists MK for emergency coverage established in good faith, MN for replacement following a dose change, and MV for a vacation supply. An OC response flags a reduced days’ supply submitted without the matching quantity reduction; NF may apply where package size prevents a further quantity reduction.

KX concerns the remaining supply after an initial trial. The bulletin says the claim has not been approved and may be resubmitted for the remaining balance; it identifies MN for a dose-change replacement. For the DR warning under the 90-day maintenance rule, the listed interventions are ER for overriding the days’ supply limit and DH for prescription synchronization under rule 19.

Intervention codes must reflect the action actually taken and have supporting documentation on the prescription hard copy. Incorrect, unacceptable or missing codes or pharmacist identification cause rejection and require correction and resubmission.

If more than three DUR messages are generated, the DD response indicates that not all warnings fit in the returned message space. The bulletin directs pharmacies to GreenShield for the remaining information and for situations where no appropriate intervention code can be identified or a D9 instruction to call the adjudicator is returned.

Compound claims use an eligible ingredient or category identifier

The bulletin distinguishes topical preparations from other compounds. Non-topical claims use the DIN or NPN of an ingredient eligible under the member’s plan. For a topical preparation, the identifier must correspond to the primary active ingredient. Where that ingredient has neither a DIN nor an NPN, GreenShield directs pharmacies to its compound PIN categories.

The insurer lists seven categories in the Ontario update. Their ingredient lists and eligibility conditions are set out in its Compound Drug Policy; a category identifier does not make every preparation in that category a covered benefit.

Compound PIN categories listed in GreenShield’s November update
PINCategory
993018Antibiotic
993026Corticosteroid
993034Antifungal
993042Skin treatment
993050Pain treatment without narcotics
993069Narcotic pain treatment
993077Miscellaneous eligible compounds

Electronic submissions also require the applicable compound code, which identifies the preparation type, and the actual preparation time. GreenShield’s bulletin calls for records of the formula, ingredient quantities and costs, preparation date, the responsible pharmacist or compounder, and documentation required by the regulator.

Online acceptance does not remove coverage or audit conditions

The update says compounds remain subject to GreenShield’s eligibility rules and audit. Preparations duplicating a commercially available product are generally excluded, with an exception for documented drug shortages. Eligible RAMQ extemporaneous compounds remain available to Quebec plan members under the stated Quebec provision.

The public compound policy adds that plan-specific variations apply. It warns that a claim may pass online adjudication using an eligible identifier but still be ineligible if another ingredient or the base is excluded. Such payments can be recovered following review.

For electronic submissions that do not go through, the bulletin identifies an official pharmacy receipt as the route for the member to seek reimbursement. The policy requires an ingredient breakdown for assessment; an unsuccessful electronic claim does not itself establish coverage.

OHIP+ comes first for eligible KARE members

GreenShield also reminds Ontario pharmacies that KARE is publicly funded and is not a private plan for OHIP+ eligibility. For eligible KARE members aged 24 or younger, OHIP+ must adjudicate first; any remaining eligible amount goes to GreenShield as secondary payer. KARE claims sent to GreenShield first will be denied, the bulletin says.

Updated claims manual carries documentation and audit requirements

The November update announces the availability of GreenShield’s updated Pharmacy Claims Manual, dated October 2026. It reminds providers that their submission agreement requires compliance with the manual, including documentation requirements and audit provisions.

References

  1. Ontario Edition – Pharmacy Update, November 2026 — GreenShield, Email bulletin distributed November 19, 2026; link to publisher’s pharmacy resources
  2. Compound Drug Policy — GreenShield, Current public policy; accessed November 19, 2026
  3. Pharmacy Claims Manual — October 2026 — GreenShield, October 2026
  4. Pharmacy Claims Manual — September 2024 — GreenShield, September 2024; historical context for initial-supply rules

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.